AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2017
Dec 8, 2017
35066_dirs_2017-12-08_7447dc4c-d569-4c2b-a3a7-b3161f554368.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2017-11-24
Reporting Person: Schinazi Raymond F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-24 | 8% Convertible Note | $0.27 | A | 1851851 | Acquired | 2019-11-24 | Common Stock (1851851) | Indirect |
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15